Protein aggregation determinants from a simplified model: Cooperative folders resist aggregation

Protein Science

Volumn 14, Issue 3, 2005, Pages 653-662

  Clark, Louis A ^a  

^a BIOGEN   (United States)

Author keywords

Aggregate structure; Aggregation oligomers; Folding cooperativity; Protein aggregation; Protein simulation

Indexed keywords

MUTANT PROTEIN; OLIGOMER; PROTEIN G; PROTEIN L; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER SIMULATION; CONFORMATIONAL TRANSITION; DENATURATION; HYDROPHOBICITY; MOLECULAR MODEL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FOLDING; THERMODYNAMICS;

AMINO ACID SEQUENCE; COMPUTER SIMULATION; MODELS, MOLECULAR; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE ALIGNMENT; TEMPERATURE;

EID: 14144256476     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.041017305     Document Type: Article

References (56)

1. Allen, M.P. and Tildesley, D.J. 1987. Computer simulation of liquids. Clarendon Press, Oxford.
2. Bennett, M.J., Schlunegger, M.P., and Eisenberg, D. 1995. 3D domain swapping - A mechanism for oligomer assembly. Protein Sci. 4: 2455-2468.
3. Bratko, D. and Blanch, H.W. 2001. Competition between protein folding and aggregation: A three-dimensional lattice-model simulation. J. Chem. Phys. 114: 561-569.
4. _. 2003. On-lattice modeling of protein aggregation: The effect of secondary structure. J. Chem. Phys. 118: 5185-5194.
5. Broglia, R.A., Tiana, G., Pasquali, S., Roman, H.E., and Vigezzi, E. 1998. Folding and aggregation of designed proteins. Proc. Natl. Acad. Sci. 95: 12930-12933.
6. Broome, B.M. and Hecht, M.H. 2000. Nature disfavors sequences of alternating polar and non-polar amino acids: Implications for amyloidogenesis. J. Mol. Biol. 296: 961-968.
7. Brown, S. and Head-Gordon, T. 2004. Intermediates and the folding of proteins L and G. Protein Sci. 13: 958-970.
8. Brown, S., Fawzi, N.J., and Head-Gordon, T. 2003. Coarse-grained sequences for protein folding and design. Proc. Natl. Acad. Sci. 100: 10712-10717.
9. Bucciantini, M., Giannoni, E., Chili, F., Baroni, F., Formigli, L., Zurdo, J.S., Taddei, N., Ramponi, G., Dobson, C.M., and Stefani, M. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
10. Chi, E.Y., Krishnan, S., Randolph, T.W., and Carpenter, J.F. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in normative protein aggregation. Pharmaceutical Res. 20: 1325-1336.
11. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C.M. 2002. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9: 137-143.
12. Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808.
13. Clark, E.D. 2001. Protein refolding for industrial processes. Curr. Opin. Struct. Biol. 12: 202-207.
14. Dima, R.I. and Thirumalai, D. 2002. Exploring protein aggregation and self-propagation using lattice models: Phase diagram and kinetics. Protein Sci. 11: 1036-1049.
15. Ding, F., Dokholyan, N.V., Buldyrev, S.V., Stanley, H.E., and Shakhnovich, E.I. 2002. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J. Mol. Biol. 324: 851-857.
16. Dinner, A.R., Abkevich, V., Shakhnovich, E., and Karplus, M. 1999. Factors that affect the folding ability of proteins. Proteins 35: 34-40.
17. Dobson, C.M. 2001. The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356: 133-145.
18. Ellis, R.J. 2001. Macromolecular crowding: An important but neglected aspect of the intracellular environment. Curr. Opin. Struct. Biol. 11: 114-119.
19. Ferguson, D.M. and Garrett, D.G. 1999. Simulated annealing - Optimal histogram methods. In Advances in chemical physics, Monte Carlo methods in chemical physics (eds. D.M. Ferguson et al.), Vol. 105, pp. 311-335. John Wiley, New York.
20. Ferrenberg, A.M. and Swendsen, R.H. 1988. New Monte Carlo technique for studying phase transitions. Phys. Rev. Lett. 61: 2635-2638.
21. Fink, A.L. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold. Des. 3: R9-R23.
22. Hammarstrom, P., Wiseman, R.L., Powers, E.T., and Kelly, J.W. 2003. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299: 713-716.
23. Harrison, P.M., Chan, H.S., Prusiner, S.B., and Cohen, F.E. 1999. Thermodynamics of model prions and its implications for the problem of prion protein folding. J. Mol. Biol. 286: 593-606.
24. Harrison, P.M., Chan, H.S., Prusiner, S.B., and Cohen, F.E. 2001. Conformational propagation with prion-like characteristics in a simple model of protein folding. Protein Sci. 10: 819-835.
25. Horwich, A. 2002. Protein aggregation in disease: A role for folding intermediates forming specific multimeric interactions. J. Clin. Invest. 110: 1221-1232.
26. Hurle, M.R., Helms, L.R., Li, L., Chan, W.N., and Wetzel, R. 1994. A role for destabilizing amino-acid replacements in light-chain amyloidosis. Proc. Natl. Acad. Sci. 91: 5446-5450.
27. Istrail, S., Schwartz, R., and King, J. 1999. Lattice simulations of aggregation funnels for protein folding. J. Comp. Biol. 6: 143-162.
28. Janowski, R., Kozak, M., Jankowska, E., Grzonka, Z., Grubb, A., Abrahamson, M., and Jaskolski, M. 2001. Human cystatin c, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8: 316-320.
29. Jiang, X., Farid, H., Pistor, E., and Farid, R.S. 2000. A new approach to the design of uniquely folded thermally stable proteins. Protein Sci. 9: 403-416.
30. Kayed, R., Head, E., Thompson, J.L., Mcintire, T.M., Milton, S.C., Cotman, C.W., and Glabe, C.G. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
31. Kelly, J.W. 2000. Mechanisms of amyloidogenesis. Nat. Struct. Biol. 7: 824-826.
32. Kirkitadze, M.D., Condron, M.M., and Teplow, D.B. 2001. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J. Mol. Biol. 312: 1103-1119.
33. Klimov, D.K. and Thirumalai, D. 1996. Criterion that determines the foldability of proteins. Phys. Rev. Lett. 76: 4070-4073.
34. _. 1998. Cooperatively in protein folding: From lattice models with sidechains to real proteins. Fold. Des. 3: 127-139.
35. _. 2003. Dissecting the assembly of Aβ (16-22) amyloid peptides into antiparallel β sheets. Structure 11: 295-307.
36. Liu, K., Cho, H.S., Lashuel, H.A., Kelly, J.W., and Wemmer, D.E. 2000. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7: 754-757.
37. Liu, Y.S., Gotte, G., Libonati, M., and Eisenberg, D. 2001. A domain-swapped RNase a dimer with implications for amyloid formation. Nat. Struct. Biol. 8: 211-214.
38. Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A., and Teplow, D.B. 1996. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. 93: 1125-1129.
39. Ma, B.Y. and Nussinov, R. 2002a. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ 16-22, Aβ 16-35, and Aβ 10-35): Sequence effects. Proc. Natl. Acad. Sci. 99: 14126-14131.
40. _. 2002b. Molecular dynamics simulations of alanine rich β-sheet oligomers: Insight into amyloid formation. Protein Sci. 11: 2335-2350.
41. Minton, A.P. 2001. The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J. Biol. Chem. 276: 10577-10580.
42. Monti, M., Garolla di Bard, B.L., Calloni, G., Chili, F., Amoresano, A., Ramponi, G., and Pucci, P. 2004. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J. Mol. Biol. 336: 253-262.
43. Nettleton, E.J., Tito, P., Sunde, M., Bouchard, M., Dobson, C.M., and Robinson, C.V. 2000. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79: 1053-1065.
44. Olofsson, A., Ostman, J., and Lundgren, E. 2002. Amyloid: Morphology and toxicity. Clin. Chem. Lab. Med. 40: 1266-1270.
45. O'Neill, J.W., Kim, D.E., Johnsen, K., Baker, D., and Zhang, K.Y.J. 2001. Single-site mutations induce 3D domain swapping in the B1 domain of protein 1 from Peptostreptococcus magnus. Structure 9: 1017-1027.
46. Roberts, C.J. 2003. Kinetics of irreversible protein aggregation: Analysis of extended Lumry-Eyring models and implications for predicting protein shelf life. J. Phys. Chem. B 107: 1194-1207.
47. Selkoe, D.J. 2003. Folding proteins in fatal ways. Nature 426: 900-904.
48. Shimizu, S. and Chan, H.S. 2001. Statistical mechanics of solvophobic aggregation: Additive and cooperative effects. J. Chem. Phys. 115: 3424-3431.
49. Smith, A.V. and Hall, C.K. 2001. Protein refolding versus aggregation: Computer simulations on an intermediate-resolution protein model. J. Mol. Biol. 312: 187-202.
50. Sorenson, J.M. and Head-Gordon, T. 1999. Redesigning the hydrophobic core of a model β-sheet protein: Destabilizing traps through a threading approach. Proteins 37: 582-591.
51. _. 2000. Matching simulation and experiment: A new simplified model for simulating protein folding. J. Comp. Biol. 7: 3-4.
52. _. 2002. Protein engineering study of protein 1 by simulation. J. Comp. Biol. 9: 35-54.
53. Speed, M.A., Morshead, T., Wang, D.I., and King, J. 1997. Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies. Protein Sci. 6: 99-108.
54. Tartaglia, G.G., Cavalli, A., Pellarin, R., and Caflisch, A. 2004. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci. 7: 1939-1941.
55. Thirumalai, D., Klimov, D.K., and Dima, R.I. 2003. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13: 146-159.
56. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., and Selkoe, D.J. 2002. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.